Safety and effectiveness of rivaroxaban and warfarin in moderate-to-advanced CKD: real world data - Concepedia

Concepedia

Publication | Closed Access

Safety and effectiveness of rivaroxaban and warfarin in moderate-to-advanced CKD: real world data

38

Citations

15

References

2018

Year

Luca Di Lullo, Giovanni Tripepi, Claudio Ronco, Antonio De Pascalis, Vincenzo Bàrbera, Antonio Granata, Domenico Russo, Biagio Di Iorio, Ernesto Paoletti, Maura Ravera,

Journal of Nephrology

Abstract

Rivaroxaban seems a safe and effective therapeutic option in CKD stage 3b-4 patients. However, future randomized controlled trials are needed to definitively establish the role of rivaroxaban in CKD patients.

References

	Year	Citations

Page 1